IFNG and systemic inflammatory response syndrome: Both biomarkers were associated with worse 5 year outcomes, independent of SIRS development (12.9% vs. 32.3%; p = 0.022 for hs-CRP and 9.6% vs. 33.2%; p = 0.029 for IFN-γ respectively) (Figures 4, 5).